Advisor – Board Member

Antonio Pineda-Lucena obtained his PhD at the Centro de Investigaciones Biológicas (CSIC, Madrid, Spain) in 1995. After that, he moved to the Netherlands (EMBO and Marie Sklodowska-Curie grants) to work as a postdoctoral researcher with Prof. Dr. Cees Hilbers at the Radboud Universiteit (Nijmegen, The Netherlands) where he pursued further training in molecular biology, protein chemistry and NMR spectroscopy. Later on, he obtained a permanent position as an Associate Scientist at the Ontario Institute for Cancer Research (Princess Margaret Hospital, Toronto, Canada), the canadian reference centre for cancer treatment. APL accepted a position as an Associate Principal Scientist in a pharmaceutical company, AstraZeneca, in Alderley Park (Manchester, United Kingdom), the biggest research centre of this company in the oncology area.

APL was recruited in 2005 by the Centro de Investigación Príncipe Felipe (CIPF, Valencia, Spain) to lead, as a Principal Investigator, the Structural Biochemistry Laboratory and the NMR facility. In may 2015, APL joined the Instituto de Investigación Sanitaria La Fe (Valencia, Spain) as Director of the Drug Discovery Unit. Four years later, APL joined at Cima Universidad de Navarra (Pamplona, Spain) where he was offered different senior management (Director of Translational Research and Deputy Director) and scientific (Director of the Molecular Therapeutics Program, Senior Investigator of the Medicinal Chemistry laboratory) positions.